Cowen Starts Bluebird Bio (BLUE) at Outperform
Tweet
Share
E-mailGet Alerts BLUE Hot Sheet
Price: $4.97 --0%
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 25
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 25
Join SI Premium – FREE
Cowen initiates coverage on Bluebird Bio (NASDAQ: BLUE) with a Outperform. PT $44.00.
For an analyst ratings summary and ratings history on Bluebird Bio click here. For more ratings news on Bluebird Bio click here.
Shares of Bluebird Bio closed at $30.85 yesterday.
For an analyst ratings summary and ratings history on Bluebird Bio click here. For more ratings news on Bluebird Bio click here.
Shares of Bluebird Bio closed at $30.85 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Starts NervGen Pharma Corp (NGEN) at Buy, 'A New Generation In Spinal Cord Injury Treatment Is Here'
- Macquarie Starts Siemens Energy India (ENRIN:IN) at Outperform
- Macquarie Starts GE Vernova T&D India (GVTD:IN) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
